View Financial HealthXinjiang Xuefeng Sci-Tech(Group)Co.Ltd 배당 및 자사주 매입배당 기준 점검 3/6Xinjiang Xuefeng Sci-Tech(Group)Co.Ltd 수익으로 충분히 충당되는 현재 수익률 1.91% 보유한 배당금 지급 회사입니다.핵심 정보1.9%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률14.3%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향33%최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesBoard Change • May 20Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Employee Representative Supervisor Jing Li is the most experienced director on the board, commencing their role in 2021. Independent Director Jin Hong Han was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.공시 • Mar 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q1, 2026 Results on Apr 17, 2026Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q1, 2026 results on Apr 17, 2026공시 • Mar 19Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Apr 09, 2026Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Apr 09, 2026, at 15:30 China Standard Time. Location: The Company's Meeting Room, Urumqi, Xinjiang China공시 • Dec 26Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Fiscal Year 2025 Results on Mar 20, 2026Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report fiscal year 2025 results on Mar 20, 2026공시 • Sep 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q3, 2025 Results on Oct 21, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q3, 2025 results on Oct 21, 2025공시 • Jun 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report First Half, 2025 Results on Aug 15, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report first half, 2025 results on Aug 15, 2025공시 • Apr 17Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, May 08, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, May 08, 2025, at 15:00 China Standard Time. Location: The Company's Meeting Room, Urumqi, Xinjiang China공시 • Mar 28Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q1, 2025 Results on Apr 25, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q1, 2025 results on Apr 25, 2025공시 • Feb 27Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) Completed the acquisition of 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd.Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) entered into Equity Transfer Framework Agreement to acquire 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. for CNY 2.2 billion on July 2, 2024. Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) signed the share purchase Agreement to acquire 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. for CNY 2.2 billion on December 11, 2024. A cash consideration valued at CNY 9.8 per share will be paid by Guangdong Hongda Holdings for 225,055,465 shares. The transaction is subject to approval or confirmation of the state-owned assets supervision and administration department, the State Administration for Market Regulation, the Shanghai Stock Exchange and other relevant competent authorities, and the application for share transfer registration through the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. As of December 11, 2024, the deal is subject to approval by the shareholders of Xinjiang Xuefeng Sci Tech(Group)Co.,Ltd and Guangdong Provincial State-owned Assets Supervision and Administration Commission. The acquisition has been approved by the Board of Directors of Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd and Xinjiang State-owned Assets Supervision and Administration Commission. Xia Xiaohui of CITIC Securities Co., Ltd. acted as a financial advisor in the deal while Huang Xiaoli of Jun He Law Offices acted as the legal advisor to Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd. Guangdong Sinong Certified Public Accountants (Special General Partnership) acted as an accountant in the deal. Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) Completed the acquisition of 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. on February 25, 2025.공시 • Dec 27Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Fiscal Year 2024 Results on Apr 17, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report fiscal year 2024 results on Apr 17, 2025Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.22 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.20 (down from CN¥0.22 in 3Q 2023). Revenue: CN¥1.74b (up 1.6% from 3Q 2023). Net income: CN¥210.1m (down 11% from 3Q 2023). Profit margin: 12% (down from 14% in 3Q 2023). The decrease in margin was driven by higher expenses.Buy Or Sell Opportunity • Oct 28Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 31% to CN¥8.55. The fair value is estimated to be CN¥7.10, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 19%.Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥8.37, the stock trades at a trailing P/E ratio of 12.1x. Average trailing P/E is 30x in the Chemicals industry in China. Total returns to shareholders of 6.1% over the past year.공시 • Sep 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q3, 2024 Results on Oct 29, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q3, 2024 results on Oct 29, 2024Reported Earnings • Aug 16Second quarter 2024 earnings released: EPS: CN¥0.25 (vs CN¥0.26 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.25 (down from CN¥0.26 in 2Q 2023). Revenue: CN¥1.64b (down 12% from 2Q 2023). Net income: CN¥266.5m (down 2.0% from 2Q 2023). Profit margin: 16% (up from 15% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China.공시 • Jun 28Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report First Half, 2024 Results on Aug 16, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report first half, 2024 results on Aug 16, 2024공시 • Jun 06Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Jun 25, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Jun 25, 2024, at 10:30 China Standard Time. Location: The Company's Meeting Room, Urumqi, Xinjiang ChinaReported Earnings • Apr 30First quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.24 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.24 in 1Q 2023). Revenue: CN¥1.18b (down 35% from 1Q 2023). Net income: CN¥125.3m (down 45% from 1Q 2023). Profit margin: 11% (down from 13% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.Reported Earnings • Apr 12Full year 2023 earnings released: EPS: CN¥0.82 (vs CN¥0.81 in FY 2022)Full year 2023 results: EPS: CN¥0.82 (up from CN¥0.81 in FY 2022). Revenue: CN¥7.02b (up 1.7% from FY 2022). Net income: CN¥853.5m (up 28% from FY 2022). Profit margin: 12% (up from 9.6% in FY 2022). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.공시 • Mar 29Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q1, 2024 results on Apr 30, 2024Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥5.63, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry in China.공시 • Dec 29Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Fiscal Year 2023 Results on Apr 11, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report fiscal year 2023 results on Apr 11, 2024Reported Earnings • Oct 21Third quarter 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.21 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.22 (up from CN¥0.21 in 3Q 2022). Revenue: CN¥1.71b (up 49% from 3Q 2022). Net income: CN¥236.0m (up 59% from 3Q 2022). Profit margin: 14% (in line with 3Q 2022).공시 • Sep 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q3, 2023 Results on Oct 27, 2023Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q3, 2023 results on Oct 27, 2023Reported Earnings • Aug 18Second quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.20 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.26 (up from CN¥0.20 in 2Q 2022). Revenue: CN¥1.85b (up 79% from 2Q 2022). Net income: CN¥271.9m (up 85% from 2Q 2022). Profit margin: 15% (in line with 2Q 2022).공시 • Jun 28Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report First Half, 2023 Results on Aug 18, 2023Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report first half, 2023 results on Aug 18, 2023Valuation Update With 7 Day Price Move • May 08Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥10.22, the stock trades at a trailing P/E ratio of 15x. Average trailing P/E is 29x in the Chemicals industry in China.Reported Earnings • Apr 28Full year 2022 earnings released: EPS: CN¥0.81 (vs CN¥0.20 in FY 2021)Full year 2022 results: EPS: CN¥0.81 (up from CN¥0.20 in FY 2021). Revenue: CN¥6.90b (up 165% from FY 2021). Net income: CN¥665.8m (up 356% from FY 2021). Profit margin: 9.6% (up from 5.6% in FY 2021). The increase in margin was driven by higher revenue.Board Change • Mar 15Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 8 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Independent Director Zu Yi Yang was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 603227 의 배당금 지급은 지난 10 년 동안 휘발성이었습니다.배당금 증가: 603227 의 배당금 지급은 지난 10 년 동안 증가했습니다.배당 수익률 vs 시장Xinjiang Xuefeng Sci-Tech(Group)Co.Ltd 배당 수익률 vs 시장603227의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (603227)1.9%시장 하위 25% (CN)0.4%시장 상위 25% (CN)2.1%업계 평균 (Chemicals)1.2%분석가 예측 (603227) (최대 3년)n/a주목할만한 배당금: 603227 의 배당금( 1.91% )은 CN 시장에서 배당금 지급자의 하위 25%( 0.37% )보다 높습니다.고배당: 603227 의 배당금( 1.91% )은 CN 시장에서 배당금 지급자의 상위 25%( 2.12% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 합리적으로 낮은 지불 비율 ( 33.1% )로 603227 의 배당금 지급은 수익으로 충분히 충당됩니다.주주 현금 배당현금 흐름 범위: 603227 배당금을 지급하고 있지만 회사에는 잉여현금흐름이 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YCN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/17 17:45종가2026/06/17 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Huaichao ZhuangHaitong International Research Limited
Board Change • May 20Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Employee Representative Supervisor Jing Li is the most experienced director on the board, commencing their role in 2021. Independent Director Jin Hong Han was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
공시 • Mar 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q1, 2026 Results on Apr 17, 2026Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q1, 2026 results on Apr 17, 2026
공시 • Mar 19Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Apr 09, 2026Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Apr 09, 2026, at 15:30 China Standard Time. Location: The Company's Meeting Room, Urumqi, Xinjiang China
공시 • Dec 26Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Fiscal Year 2025 Results on Mar 20, 2026Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report fiscal year 2025 results on Mar 20, 2026
공시 • Sep 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q3, 2025 Results on Oct 21, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q3, 2025 results on Oct 21, 2025
공시 • Jun 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report First Half, 2025 Results on Aug 15, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report first half, 2025 results on Aug 15, 2025
공시 • Apr 17Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, May 08, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, May 08, 2025, at 15:00 China Standard Time. Location: The Company's Meeting Room, Urumqi, Xinjiang China
공시 • Mar 28Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q1, 2025 Results on Apr 25, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q1, 2025 results on Apr 25, 2025
공시 • Feb 27Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) Completed the acquisition of 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd.Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) entered into Equity Transfer Framework Agreement to acquire 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. for CNY 2.2 billion on July 2, 2024. Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) signed the share purchase Agreement to acquire 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. for CNY 2.2 billion on December 11, 2024. A cash consideration valued at CNY 9.8 per share will be paid by Guangdong Hongda Holdings for 225,055,465 shares. The transaction is subject to approval or confirmation of the state-owned assets supervision and administration department, the State Administration for Market Regulation, the Shanghai Stock Exchange and other relevant competent authorities, and the application for share transfer registration through the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. As of December 11, 2024, the deal is subject to approval by the shareholders of Xinjiang Xuefeng Sci Tech(Group)Co.,Ltd and Guangdong Provincial State-owned Assets Supervision and Administration Commission. The acquisition has been approved by the Board of Directors of Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd and Xinjiang State-owned Assets Supervision and Administration Commission. Xia Xiaohui of CITIC Securities Co., Ltd. acted as a financial advisor in the deal while Huang Xiaoli of Jun He Law Offices acted as the legal advisor to Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd. Guangdong Sinong Certified Public Accountants (Special General Partnership) acted as an accountant in the deal. Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) Completed the acquisition of 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. on February 25, 2025.
공시 • Dec 27Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Fiscal Year 2024 Results on Apr 17, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report fiscal year 2024 results on Apr 17, 2025
Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.22 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.20 (down from CN¥0.22 in 3Q 2023). Revenue: CN¥1.74b (up 1.6% from 3Q 2023). Net income: CN¥210.1m (down 11% from 3Q 2023). Profit margin: 12% (down from 14% in 3Q 2023). The decrease in margin was driven by higher expenses.
Buy Or Sell Opportunity • Oct 28Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 31% to CN¥8.55. The fair value is estimated to be CN¥7.10, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 19%.
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥8.37, the stock trades at a trailing P/E ratio of 12.1x. Average trailing P/E is 30x in the Chemicals industry in China. Total returns to shareholders of 6.1% over the past year.
공시 • Sep 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q3, 2024 Results on Oct 29, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q3, 2024 results on Oct 29, 2024
Reported Earnings • Aug 16Second quarter 2024 earnings released: EPS: CN¥0.25 (vs CN¥0.26 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.25 (down from CN¥0.26 in 2Q 2023). Revenue: CN¥1.64b (down 12% from 2Q 2023). Net income: CN¥266.5m (down 2.0% from 2Q 2023). Profit margin: 16% (up from 15% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China.
공시 • Jun 28Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report First Half, 2024 Results on Aug 16, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report first half, 2024 results on Aug 16, 2024
공시 • Jun 06Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Jun 25, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Jun 25, 2024, at 10:30 China Standard Time. Location: The Company's Meeting Room, Urumqi, Xinjiang China
Reported Earnings • Apr 30First quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.24 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.24 in 1Q 2023). Revenue: CN¥1.18b (down 35% from 1Q 2023). Net income: CN¥125.3m (down 45% from 1Q 2023). Profit margin: 11% (down from 13% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.
Reported Earnings • Apr 12Full year 2023 earnings released: EPS: CN¥0.82 (vs CN¥0.81 in FY 2022)Full year 2023 results: EPS: CN¥0.82 (up from CN¥0.81 in FY 2022). Revenue: CN¥7.02b (up 1.7% from FY 2022). Net income: CN¥853.5m (up 28% from FY 2022). Profit margin: 12% (up from 9.6% in FY 2022). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.
공시 • Mar 29Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q1, 2024 results on Apr 30, 2024
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥5.63, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry in China.
공시 • Dec 29Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Fiscal Year 2023 Results on Apr 11, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report fiscal year 2023 results on Apr 11, 2024
Reported Earnings • Oct 21Third quarter 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.21 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.22 (up from CN¥0.21 in 3Q 2022). Revenue: CN¥1.71b (up 49% from 3Q 2022). Net income: CN¥236.0m (up 59% from 3Q 2022). Profit margin: 14% (in line with 3Q 2022).
공시 • Sep 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q3, 2023 Results on Oct 27, 2023Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q3, 2023 results on Oct 27, 2023
Reported Earnings • Aug 18Second quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.20 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.26 (up from CN¥0.20 in 2Q 2022). Revenue: CN¥1.85b (up 79% from 2Q 2022). Net income: CN¥271.9m (up 85% from 2Q 2022). Profit margin: 15% (in line with 2Q 2022).
공시 • Jun 28Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report First Half, 2023 Results on Aug 18, 2023Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report first half, 2023 results on Aug 18, 2023
Valuation Update With 7 Day Price Move • May 08Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥10.22, the stock trades at a trailing P/E ratio of 15x. Average trailing P/E is 29x in the Chemicals industry in China.
Reported Earnings • Apr 28Full year 2022 earnings released: EPS: CN¥0.81 (vs CN¥0.20 in FY 2021)Full year 2022 results: EPS: CN¥0.81 (up from CN¥0.20 in FY 2021). Revenue: CN¥6.90b (up 165% from FY 2021). Net income: CN¥665.8m (up 356% from FY 2021). Profit margin: 9.6% (up from 5.6% in FY 2021). The increase in margin was driven by higher revenue.
Board Change • Mar 15Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 8 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Independent Director Zu Yi Yang was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.